Board Members

Janet Roemer
Janet Roemer

Ms. Roemer recently retired as Chief Operating Officer of Verenium, an industrial biotechnology company. Prior to that, she was a senior executive in the chemical industry and has extensive experience in the operational management of large scale, global businesses. Ms. Roemer holds a B.S. in chemistry from Miami University and an MBA from the University of Chicago. She has three grown children and enjoys travel, golf, and hiking with her dog. She joined the Board in 2015.

Marla Shepard
Marla Shepard

Ms. Shepard recently retired as the President & CEO of California Coast Credit Union. She has board experience with Jack Henry & Associates (publicly traded for-profit financial technology company) Compensation committee and Governance Chair, CA Credit Union League, Children's Miracle Network, SD Credit Unions PAC, Richard Myles Johnson Foundation. She has a business degree from Mesa College in Colorado. Ms. Shepard enjoys spending off-time in Alaska where she and her husband have owned a series of second homes hosting friends and family. Ms. Shepard has served on the Board since 2015.

Laura Clapper, M.D.
Dr. Laura Clapper, M.D.

Laura Clapper, M.D., the Chief Medical Officer of FemTec Health, has 30+ years of multi-industry experience with small, mid-sized companies and iconic companies such as Cigna, Anthem, Aetna, and Health Net as well as serving in the Navy for 14 years. Currently, as the CMO of FemTec Health, she is leading their vision for reinventing women’s health by providing a modern wellness home including women’s health primary/urgent care and incorporating women-centric digital health solutions leveraging predictive analytics, technology, and science. In leading the FemTec Health Clinical team, Dr. Clapper brings her experience in analytics, consumer marketing, health promotion, and healthcare systems to FemTec Health’s execution. She has served in the physician leadership at several health plans and provider organizations where she has been responsible for clinical strategy population health management, total medical cost and provider partnerships, and leadership in National Accounts. 

Throughout her work with plans and the providers, Dr. Clapper focused on improving medical operations management, integration of Behavior Health and pharmacy, and enhancing programs to provide patients with the highest quality of care. As a Navy veteran, she has provided care from a global perspective and early on, learned the power of virtual care and technology to enhance the quality and experience of care in the community, hospital, and in remote locations. While a hospital medical director, Dr. Clapper led her hospital to the first WHO certification of a California hospital as Baby Friendly. She received her undergraduate degree from Stanford University, her Medical Degree from The Uniformed Services University School of Medicine in Bethesda, MD, and a Master’s in Public Policy and Health Economics from Claremont’s Drucker Business School and completed her residency at the National Medical Center Bethesda, MD in Pediatrics.  

Dr. Clapper is a board-certified pediatrician and lactation consultant. Dr. Clapper has taught at Stanford University on topics related to healthcare technology, services, and innovation, and is a mentor in the new Stanford Clinical Informatics Management Master’s Program. In addition, she holds an academic appointment with the University of California, San Diego. Dr. Clapper joined the Board in 2016.

Robert (Bob) Finzi, Secretary
Robert (Bob) Finzi

Mr. Finzi, now retired, was a Senior Advisor to Credit Suisse serving on the Investment Committees of Credit Suisse Direct Equity Partners and Hudson Clean Energy. Previously he served as Managing Partner of the Sprout Group, Credit Suisse’s venture capital affiliate, and a General Partner of Merrill Lynch Venture Capital, which was merged into Sprout in 1991. Mr. Finzi serves on a number of for-profit and not-for-profit Boards of Directors. Mr. Finzi has a BS & MS in Industrial Engineering from Lehigh University and an MBA from Harvard Business School. He has twin daughters, is fluent in Italian and his hobbies include fishing and cooking. Mr. Finzi has served on the Board since 2015. 

Jean-Claude "JC" Kyrillos, Past Chair
JC Kyrillos

Jean-Claude "JC" Kyrillos is a long-time medical device and digital health executive. Mr. Kyrillos is SVP and President of the Envista Holdings (NYSE:  NVST) KaVo Equipment operating company, which is a leading global solution provider to dental professionals of drill instruments, treatment units and imaging hardware and software. Mr. Kyrillos has 30 years of diversified business experience, including 20 years of executive leadership in the medical device industry serving acute care, homecare, and diagnostics including leadership roles with Becton Dickinson/CareFusion Corporation and Qualcomm Life. At Qualcomm, he was the SVP and GM of the healthcare division powering intelligent healthcare from hospital to home, including medical device information systems, connected pharmaceuticals, and predictive analytics. At BD/CareFusion, JC led the Alaris infusion pump division. Prior to that, JC served in various President and Senior Vice President roles at ResMed, Inc. Mr. Kyrillos serves as a student mentor for children who are the first generation from their family to attend college via A Bridge for Kids and the Georgetown Scholarship Program. He formerly served for many years on the Board of Directors for the Sharp Healthcare Foundation. He earned an MBA from Harvard Business School and a BA with Honors in History from Colgate University. Mr. Kyrillos joined the Board in 2016.

Eve Benton, Chair
Eve Benton

Ms. Benton serves as the SDBB Board Chair effective January 1, 2022. Ms. Benton is an entrepreneur who has experience managing both for-profit and non-profit organizations. She was a general partner in a private equity firm in Washington DC for 25 years. She is the founder and board member for Vehicles for Change, Inc., a non-profit that awards automobiles to working poor families and trains previously incarcerated individuals to become auto mechanics. Ms. Benton is a graduate of the Harvard Business School.  In addition to being Chairman of the San Diego Blood Bank, she serves on the board of the Moores Cancer Center at UCSD, the San Diego Humane Society, and the Salk Institute Cancer Advisory Board. Ms. Benton has lived in San Diego since 2011.

Susan Stone, Ph.D.
Susan Stone, Ph.D.

Dr. Susan Stone is currently the Chief Executive Officer of Sharp Coronado Hospital and Senior Vice President of Hospital Laboratory Services for Sharp HealthCare. Dr. Stone joined Sharp HealthCare in 1986 holding numerous leadership positions including Chief Nursing Officer for two of Sharp’s seven hospitals.

Dr. Stone’s research has been featured in the peer reviewed Health Environments Research and Design Journal, she was a contributing author to the 2008 Patient-Centered Care Improvement Guide and she served on the Planetree International Board of Directors from 2013-2019. In recognition of Dr. Stone’s ongoing efforts to improve the lives of women and girls and her efforts to improve community wellness, she was named as the 2019 Soroptimist of Coronado Legend. She earned her Bachelor of Nursing Science at San Diego State University, a Master and Doctorate of Philosophy in Nursing Science at the University of San Diego and is a fellow of the American College of Healthcare Executives. Dr. Stone joined the Board in 2020.

Jamie Levine
Jamie Levine

Mr. Levine is CFO of Cardiff Oncology, a San Diego-based biotechnology company developing new treatment options for cancer. Prior to that, he held senior executive and Board roles at three biotechnology companies, Cidara Therapeutics, Sapphire Energy and Verenium Corporation. Mr. Levine was a Managing Director in the investment banking division of Goldman Sachs & Co. Mr. Levine holds a BA in Economics from Brandeis University and an MBA from the Wharton School of the University of Pennsylvania. He joined the Board in 2020.

Rena Bradham
Rena Bradham

Rena Bradham is a Global Marketing Executive. She has more than 24 years of experience in the medical device industry and a proven track record in global and domestic marketing, strategy development and execution, product development and launch excellence, and lifecycle management, as well as customer insights, product innovation, market development, sales and marketing communications, and training development.

Most recently, Ms. Bradham led the global marketing team at Qualcomm Life. In this role, she drove global strategic marketing including commercialization strategy, communications, brand, sales collateral and launch. Ms. Bradham also led a global marketing and strategy team for a .1B in revenue (Medication Management Solutions) division of Becton Dickinson. Before that, she held various executive and marketing leadership positions at companies including CareFusion, Smiths Medical, Intraluminal Therapeutics, and Boston Scientific. Her healthcare experience includes hospital, home care and direct to patient/consumer, in large companies and startups.

Ms. Bradham holds a double Bachelor of Arts in Economics and History from University of California, Los Angeles, and an MBA from Santa Clara University. Ms. Bradham joined the Board in 2020.

Lauren Silverman, Ph.D.

Dr. Silverman retired as a Managing Director of the Novartis Venture Fund in Cambridge, MA. Prior to joining NVF, she was Global Head of Oncology Research Operations for the Novartis Institutes for Biomedical Research, and Director of Business Development and Licensing at Pfizer and OSI Pharmaceuticals. Dr. Silverman was a founding scientist of Cadus Pharmaceuticals. She continues to provide consulting services in the biotechnology arena. Dr. Silverman is also very active in the non-profit community in the San Diego area with organizations such as the Bilateral Safety Corridor Coalition, The American Academy of Pediatrics, The Humane Society of San Diego, and Encinitas Coastal Rotary.

Dr. Silverman earned her Ph.D. in molecular biology from the University of Utah, followed by fellowships at Princeton and Memorial Sloan Kettering. Dr. Silverman joined the Board in 2020.

Steve Rowles

Steve Rowles is an attorney and Chair of Morrison Foerster San Diego Corporate Group, Managing Partner of the San Diego office, and firmwide co-chair of the Emerging Companies & Venture Capital Group. He has practiced in San Diego for over 25 years and has a wealth of experience as corporate counsel to public and private companies, and the venture capital and private equity funds that invest in those companies.

He counsels companies at all stages in their life cycles. He distinguishes himself by achieving successful outcomes for clients utilizing best in class negotiating skills and creative and strategic thinking. He has been instrumental in starting, building and exiting numerous emerging growth companies in a broad range of industries including biotech, medical devices, digital health, diagnostics, healthcare services, clean technology and renewable energy, cybersecurity, fintech, agtech, software, 5G, semiconductors, telecommunications, e-commerce, new media and social networking.

Steve joined the SDBB Board of Directors in 2021.

Cheryl Kim, Treasurer

Cheryl Kim has served in finance leadership roles over her 30+ year career. Most recently she served as CFO for Healthline.com, the leading healthcare information platform where she served on the executive team driving exponential growth under private equity ownership. She led the sale of Healthline.com twice as well as several acquisitions for the company. She currently is performing consulting services for multiple fast growing healthcare companies. She obtained her B.B.A in accounting from the University of Iowa and obtained her CPA in California. 

Ms. Kim joined the Board in 2021.

Gabe Gutierrez
Gabe Gutierrez

Gabe Gutierrez is a Program Coordinator for the Strategy and Innovation Division of the County of San Diego Health and Human Services Agency. Gabe earned a Master of Public Administration from San Diego State University, School of Public Administration. With respect to boards and commissions, Gabe is the former Chairman of the Chula Vista Planning Commission. He is also proud to be a 15-gallon donor with the San Diego Blood Bank. Gabe is married with two daughters. In his spare time, he enjoys visiting the region's parks. Gabe joined the Board in 2021.

Wayne Meyer
Wayne Meyer

Mr. Meyer is the Founder and CEO of MeyWay LLC, a business advisory practice, where he shares his 27 years of CEO experience and knowledge, in business planning and development, team building and leadership mentoring to small and medium size businesses

He holds a bachelor’s degree in Accounting from the University of the Witwatersrand, Johannesburg, and was a member the Institute of Chartered Accountants South Africa and Australia.

Mr. Meyer has been donating blood with the San Diego Blood Bank since 1990. He is a dedicated platelet donor, a husband, the father of two and grandfather of four.

Mr. Meyer joined the Board in 2021.

Kazeem Omidiji
Kazeem Omidiji

Kazeem Omidiji is Director of Community Relations for the San Diego Gas & Electric Company (SDG&E), a wholly-owned subsidiary of Sempra Energy, a Fortune 500 company based in San Diego, California. Kazeem is responsible for SDG&E’s corporate philanthropy and relations with non-profit and community-based organizations in San Diego County and south Orange County. Previously, he worked for KPMG US LLP as a Manager within the Deal, Advisory, & Strategy practice focusing on strategy consulting in the digital transformation space for the Utilities and Transportation sectors.  His career includes several positions in engineering, external affairs, regulatory affairs, and construction within the Energy sector.
 
Kazeem holds a Bachelor of Science degree in Electrical Engineering from the University of Nevada – Las Vegas. He previously served on Boards for the Central San Diego Black Chamber of Commerce, Villa Musica, National Society of Black Engineers, and the Sempra Employee Giving Network. Mr. Kazeem Omidiji joined the SDBB Board in 2021.

Kenneth Cohen

Kenneth Cohen is an independent adviser to entrepreneurs, companies, and investors, primarily in the life sciences, and an experienced corporate director and board chairman. Ken was previously Co-founder, President, and CEO of Somaxon Pharmaceuticals, a specialty pharmaceutical company. He was President and CEO of Synbiotics Corporation, a veterinary diagnostics company, and was Executive Vice President and COO for Canji, a gene-therapy company, until its acquisition by Schering- Plough in 1996. He served as Vice President of Business Affairs at Argus Pharmaceuticals and VP of Marketing & Business Development for LifeCell Corporation. Ken held numerous positions during 10 years at Eli Lilly, including Director of Business Planning for Medical Instrument Systems, which became Guidant, and managed the launch of Prozac®, one of the most successful drugs in history.

Ken received his A.B. degree from Dartmouth College and an M.B.A. from the Wharton School. In 1999, in recognition of his contributions to French-American business, the President of France named Ken a Chevalier of the National Order of Merit.

Mr. Cohen has been an advisor to and director of multiple pharmaceutical, medical device, and biotechnology companies. He is presently Chief Business Advisor to Pellficure Pharmaceuticals. Ken is Chairman Emeritus and a current member of the Board of    

Trustees of the San Diego Humane Society, a leading charitable organization with more than 600 employees.

Mr Cohen has been donating blood since 1974 and joined the Board in 2022.